Literature DB >> 25348610

Nutritional strategy to prevent fatty liver and insulin resistance independent of obesity by reducing glucose-dependent insulinotropic polypeptide responses in mice.

Farnaz Keyhani-Nejad1, Martin Irmler, Frank Isken, Eva K Wirth, Johannes Beckers, Andreas L Birkenfeld, Andreas F H Pfeiffer.   

Abstract

AIMS/HYPOTHESIS: High intake of carbohydrates, particularly sucrose, in western societies is associated with the development of non-alcoholic fatty liver (NAFL) and diabetes mellitus. It is unclear whether this is related primarily to the carbohydrate quantity or to the hormonal responses, particularly glucose-dependent insulinotropic polypeptide (GIP), which is released in the proximal intestine. Therefore, we investigated the role of GIP by comparing two glucose-fructose dimers, sucrose and Palatinose (isomaltulose), resorbed proximally or distally.
METHODS: The glycaemic and incretin responses to sucrose and Palatinose were studied by oral gavage and meal tests. We then analysed phenotypic and metabolic diet-induced changes in C57Bl/6J mice exposed to isoenergetic diets differing in carbohydrate type. Studies were repeated in GIP receptor knockout (Gipr(-/-)) mice and their wild-type littermates.
RESULTS: Compared with sucrose, Palatinose intake resulted in slower glucose absorption and reduced postprandial insulin and GIP levels. After 22 weeks, Palatinose feeding prevented hepatic steatosis (48.5%) compared with sucrose and improved glucose tolerance, without differences in body composition and food intake. Ablation of GIP signalling in Gipr(-/-) mice completely prevented the deleterious metabolic effects of sucrose feeding. Furthermore, our microarray analysis indicated that sucrose increased 2.3-fold the hepatic expression of Socs2, which is involved in the growth hormone signalling pathway and participates in the development of NAFL. CONCLUSIONS/
INTERPRETATION: Our results suggest that the site of glucose absorption and the GIP response determine liver fat accumulation and insulin resistance. GIP may play a role in sucrose induced fatty liver by regulating the expression of Socs2.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25348610     DOI: 10.1007/s00125-014-3423-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  44 in total

1.  Control of oxidative stress and metabolic homeostasis by the suppression of postprandial hyperglycemia.

Authors:  Eiji Takeda; Hidekazu Arai; Hironori Yamamoto; Hisami Okumura; Yutaka Taketani
Journal:  J Med Invest       Date:  2005-11

2.  Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat.

Authors:  P Tollet-Egnell; A Flores-Morales; A Stavréus-Evers; L Sahlin; G Norstedt
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

3.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.

Authors:  Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Journal:  Hepatology       Date:  2003-04       Impact factor: 17.425

Review 4.  Adiponectin and adiponectin receptors.

Authors:  Takashi Kadowaki; Toshimasa Yamauchi
Journal:  Endocr Rev       Date:  2005-05       Impact factor: 19.871

5.  Studies on absorption and metabolism of palatinose (isomaltulose) in rats.

Authors:  Hidekazu Tonouchi; Taketo Yamaji; Masayuki Uchida; Megumi Koganei; Akina Sasayama; Tetsuo Kaneko; Yoshihisa Urita; Masahiro Okuno; Kouji Suzuki; Jun Kashimura; Hajime Sasaki
Journal:  Br J Nutr       Date:  2011-01       Impact factor: 3.718

6.  RS4-type resistant starch prevents high-fat diet-induced obesity via increased hepatic fatty acid oxidation and decreased postprandial GIP in C57BL/6J mice.

Authors:  Akira Shimotoyodome; Junko Suzuki; Daisuke Fukuoka; Ichiro Tokimitsu; Tadashi Hase
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-15       Impact factor: 4.310

7.  Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism.

Authors:  Yong Fan; Ram K Menon; Pinchas Cohen; David Hwang; Thomas Clemens; Douglas J DiGirolamo; John J Kopchick; Derek Le Roith; Massimo Trucco; Mark A Sperling
Journal:  J Biol Chem       Date:  2009-05-21       Impact factor: 5.157

8.  Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.

Authors:  Daniel Kraus; Qin Yang; Dong Kong; Alexander S Banks; Lin Zhang; Joseph T Rodgers; Eija Pirinen; Thomas C Pulinilkunnil; Fengying Gong; Ya-chin Wang; Yana Cen; Anthony A Sauve; John M Asara; Odile D Peroni; Brett P Monia; Sanjay Bhanot; Leena Alhonen; Pere Puigserver; Barbara B Kahn
Journal:  Nature       Date:  2014-04-10       Impact factor: 49.962

Review 9.  Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.

Authors:  Andreas L Birkenfeld; Gerald I Shulman
Journal:  Hepatology       Date:  2014-02       Impact factor: 17.425

10.  The Anti-Obesity Effect of the Palatinose-Based Formula Inslow is Likely due to an Increase in the Hepatic PPAR-alpha and Adipocyte PPAR-gamma Gene Expressions.

Authors:  Kaoru Matsuo; Hidekazu Arai; Kazusa Muto; Makiko Fukaya; Tadatoshi Sato; Akira Mizuno; Masae Sakuma; Hisami Yamanaka-Okumura; Hajime Sasaki; Hironori Yamamoto; Yutaka Taketani; Toshio Doi; Eiji Takeda
Journal:  J Clin Biochem Nutr       Date:  2007-05       Impact factor: 3.114

View more
  9 in total

1.  Comparative Effects of Bile Diversion and Duodenal-Jejunal Bypass on Glucose and Lipid Metabolism in Male Diabetic Rats.

Authors:  Xiang Zhang; Teng Liu; Yanmin Wang; Mingwei Zhong; Guangyong Zhang; Shaozhuang Liu; Tongzhi Wu; Christopher K Rayner; Sanyuan Hu
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

2.  Dysregulation of Lipid and Glucose Homeostasis in Hepatocyte-Specific SLC25A34 Knockout Mice.

Authors:  Nairita Roy; Frances Alencastro; Bayley A Roseman; Sierra R Wilson; Evan R Delgado; Meredith C May; Bharat Bhushan; Fiona M Bello; Michael J Jurczak; Sruti Shiva; Joseph Locker; Sebastien Gingras; Andrew W Duncan
Journal:  Am J Pathol       Date:  2022-06-16       Impact factor: 5.770

3.  Effects of a Follow-On Formula Containing Isomaltulose (Palatinose™) on Metabolic Response, Acceptance, Tolerance and Safety in Infants: A Randomized-Controlled Trial.

Authors:  M Fleddermann; A Rauh-Pfeiffer; H Demmelmair; L Holdt; D Teupser; B Koletzko
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

Review 4.  Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop.

Authors:  Harry P F Peters; Patrick Schrauwen; Petra Verhoef; Christopher D Byrne; David J Mela; Andreas F H Pfeiffer; Ulf Risérus; Frits R Rosendaal; Vera Schrauwen-Hinderling
Journal:  J Nutr Sci       Date:  2017-05-08

5.  Effects of isomaltulose on insulin resistance and metabolites in patients with non‑alcoholic fatty liver disease: A metabolomic analysis.

Authors:  Takumi Kawaguchi; Dan Nakano; Tetsuharu Oriishi; Takuji Torimura
Journal:  Mol Med Rep       Date:  2018-06-26       Impact factor: 2.952

Review 6.  Incretin Hormones: The Link between Glycemic Index and Cardiometabolic Diseases.

Authors:  Teresa Salvatore; Riccardo Nevola; Pia Clara Pafundi; Lucio Monaco; Carmen Ricozzi; Simona Imbriani; Luca Rinaldi; Ferdinando Carlo Sasso
Journal:  Nutrients       Date:  2019-08-13       Impact factor: 5.717

7.  Changes in Weight and Substrate Oxidation in Overweight Adults Following Isomaltulose Intake During a 12-Week Weight Loss Intervention: A Randomized, Double-Blind, Controlled Trial.

Authors:  Helen Lightowler; Lisa Schweitzer; Stephan Theis; Christiani Jeyakumar Henry
Journal:  Nutrients       Date:  2019-10-04       Impact factor: 5.717

Review 8.  The metabolic vascular syndrome - guide to an individualized treatment.

Authors:  Markolf Hanefeld; Frank Pistrosch; Stefan R Bornstein; Andreas L Birkenfeld
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

9.  Leucrose, a Sucrose Isomer, Suppresses Hepatic Fat Accumulation by Regulating Hepatic Lipogenesis and Fat Oxidation in High-fat Diet-induced Obese Mice.

Authors:  Jihye Lee; Eunju Kim; Yuri Kim; Sang-Ho Yoo
Journal:  J Cancer Prev       Date:  2018-06-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.